SNDL Inc.
corporate_fare Company Profile
SNDL Inc. (NASDAQ:SNDL) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 10 items for SNDL at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-09-08, rated 7/10. Across its 10 most recent items scored 7 or higher, the top rating is 9/10, with 4 rated 8 or above. Recent SEC coverage for SNDL spans 6-K, 40-F.
Recent high-impact activity:
- SNDL Seeks Shareholder Approval for 1:2–1:10 Reverse Split to Regain Nasdaq Compliance
- SNDL Passes EU-GMP Audit, Opening Door to International Medical Cannabis Markets
- SNDL Posts C$7.8M Q2 Loss Amid Compressed Margins
- SNDL Q2 Loss Widens, Gross Margin Compresses; Parallel Restructuring Completed, Paving Way for U.S. Cannabis Consolidation
- SNDL Closes Parallel Acquisition, Gains 56 U.S. Cannabis Stores and $150M Revenue Platform
Financial Snapshot
Insider Transactions
SNDL files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.